Iqvia price target raised to $281 from $255 at Stifel

Stifel analyst Shlomo Rosenbaum raised the firm’s price target on Iqvia to $281 from $255 and keeps a Buy rating on the shares. The company had expected to see some improvement around clients’ starting consulting and analytics projects by now, but this has yet to happen, leading the company to conclude the current “client cautiousness” will continue through the year, the analyst tells investors. Stifel believes this will be a several quarter phenomenon, but not a change in the outlook for the business in general.